Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Monday, January 20, 2025.
SAB Biotherapeutics, Inc. (NASDAQ:SABS)
Crossroads (-60) - SABS is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid SABS?
MarketClub looks at technical strength and momentum to determine if the timing is right for SABS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for SABS
The long-term trend has been UP since Nov 1st, 2024 at 3.39
The intermediate-term trend has been DOWN since Jan 15th, 2025 at 3.50
The short-term trend has been DOWN since Jan 14th, 2025 at 3.60
Smart Scan Analysis for SABS
Based on our trend formula, SABS is rated as a -60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 3.570 | 3.640 | 3.323 | 3.530 | -0.030 |
| Prev. Close | Volume | Bid | Ask | Time |
| 3.530 | 77713 | 2025-01-17 15:59:51 |
| 52wk High | 6.3 | 52wk High Date | 2024-03-15 |
| 52wk Low | 2.16 | 52wk Low Date | 2024-08-14 |
| Average Volume | 69,406 | Shares Outstanding | 9,229 |
| Assets | 53,797,183M | Liabilities | 16,894,566M |
| P/E Ratio | -1.03510000 |